Overview

Irrisept Trauma Study

Status:
Recruiting
Trial end date:
2024-04-05
Target enrollment:
0
Participant gender:
All
Summary
Early debridement and definitive fixation, at the initial operative setting, historically led to no difference in the infection rates for Gustilo-Anderson type III open tibia fractures. However, Lenarz et al. reported that delaying definitive fixation in open tibia fractures could decrease the deep infection rate. At the University of Missouri, the investigators found that staged procedures, including initial debridement-temporary fixation and delayed definitive fixation, did not statistically decrease the rate of deep infection in Gustilo-Anderson type III fractures, prompting the study that is being proposed here. Antibiotic cement coated intramedullary nails have been used in management of infected long bone fractures. Since external fixation and staged debridement did not decrease type III open tibia infection rate, the investigators wanted to consider using antibiotic cement coated nails to deliver antibiotics locally in the acute open fracture setting to prophylactically decrease associated infection rate. Additionally, Irrisept is a wound irrigant that has been used to lower infection rates in different wound settings. To the investigators' knowledge, there are no robust data showing its effectiveness at lowering infection rates in open tibia fracture management. The purpose of this study is to determine the effects of Irrisept and antibiotic nails on lowering deep infection rates in type III open tibia fractures.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Brett Crist
Criteria
Inclusion Criteria:

1. Adult, 18 or over

2. Gustilo-Anderson type III open tibia fracture

3. Able to obtain informed consent from patient

Exclusion Criteria:

1. Minor, under 18

2. Pregnancy

3. Prisoner

4. Allergic to chlorhexidine gluconate

5. Allergic to vancomycin or tobramycin

6. Patient's tibia is unable to accommodate the smallest antibiotic nail

7. Unable to provide informed consent